Europe Pharmacy Automation Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2024 –2030 |
Market Size (Base Year) |
|
Market Size (Forecast Year) |
|
CAGR |
|
Major Markets Players |
>欧洲药房自动化市场,按产品(系统、软件和服务)、药房类型(独立、连锁和联邦)、药房规模(大型药房、中型药房和小型药房)、应用(药品分配和包装、药品储存和库存管理)、最终用户(住院药房、门诊药房、零售药房、网上药房、中央配药/邮购药房、药房福利管理组织等)、分销渠道(直接招标和第三方分销商)划分 - 行业趋势和预测到 2030 年。
欧洲药房自动化市场分析与洞察
因用药失误导致的事故和死亡事件不断增加,给整个医疗行业带来了巨大压力。医护人员和药剂师都在寻找更有效、更准确的解决方案,以避免此类频繁发生的医疗事故。此外,随着患者和访客数量不断增加,以及他们各自的安全需求不断增加,药物输送系统也变得越来越复杂。为了解决这一严重问题,药房自动化系统等先进技术正成为最有力的工具。这些工具的目标是减少医疗处方错误并最大限度地保障患者安全。因此,实施此类药房自动化系统有助于医疗服务提供商和药剂师最大限度地减少损失并提高质量和生产力。
此外,技术创新的实施和自动化系统的进步,以及改进的药房自动化系统,带来了更高的成功率,而设备的新应用以及对处方药配制、分配、储存和贴标创新产品的需求增加,正在推动预测期内的市场增长。然而,预计诸如药房自动化系统成本高昂而不愿实施等因素将限制其采用,从而抑制市场增长。
欧洲药房自动化市场支持性强,旨在减少药物分配错误并提高患者安全。Data Bridge Market Research 分析称,在 2023 年至 2030 年的预测期内,欧洲药房自动化市场将以 9.6% 的复合年增长率增长。
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史性的一年 |
2021(可定制为 2015 - 2020) |
定量单位 |
收入(百万美元)和定价(美元) |
涵盖的领域 |
Product (Systems, Software, and Services), Pharmacy Type (Independent, Chain, and Federal), Pharmacy Size (Large Size Pharmacy, Medium Size Pharmacy, and Small Size Pharmacy), Application (Drug Dispensing and Packaging, Drug Storage, and Inventory Management), End User (Inpatient Pharmacies, Outpatient Pharmacies, Retail Pharmacies, Online Pharmacies, Central Fill/Mail Order Pharmacies, Pharmacy Benefit Management Organizations, and Others), Distribution Channel (Direct Tender and Third Party Distributor) |
Countries Covered |
Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, rest of Europe |
Market Players Covered |
ARxIUM, OMNICELL INC., Cerner Corporation, Capsa Healthcare, ScriptPro LLC, RxSafe, LLC., MedAvail Technologies, Inc., Asteres Inc., InterLink AI, Inc., BD, Baxter, Fullscript, McKesson Corporation, Innovation Associates, AmerisourceBergen Corporation, UNIVERSAL LOGISTICS HOLDINGS, INC, Takazono Corporation, TOSHO Inc., Willach Group, BIQHS, Synergy Medical, Yuyama, APD Algoritmos Procesos y Diseños S.A, JVM Europe BV, Genesis Automation LTD, myPak Solutions Pty Ltd., Demodeks Pharmacy Shelving, Deenova S.r.l., KUKA AG, and KLS Pharma Robotics GmbH among others |
Market Definition
Pharmacy automation plays a significant role in modern healthcare as it allows medicine to be conveniently delivered and distributed in the hospital pharmacy or retail pharmacy. Automation of the pharmacy helps to reduce the error in the medication. It prevents errors such as missing medication information, missing patient information, dispensing formulations, prescription errors, tracking therapy, and others that can occur during the manual process. One of the most common types of errors is incorrect labeling information and instructions. To improve healthcare facilities and services and to ensure patient safety, it is vital to reduce prescription error, which is why the pharmacy automation system is used in quite important ways to eliminate storage, inventory, usage, and retrieval error. The use of pharmacy automation is highly acceptable and beneficial in increasing the efficiency and accuracy of pharmacies. Furthermore, the need for preventing medication errors and the rising geriatric population across the globe are likely to boost the market growth in the forecast period.
Europe Pharmacy Automation Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
- Growing Need to Minimize Medication Errors
Medical errors are the leading cause of death in countries, further leading to increased hospitalization worldwide. Medication errors are of various types that include errors in the chain of pharmacological and pharmaceutical patient care: prescription errors, dispensing errors, administration errors, transcription errors, prescribing faults, and ‘across settings’ errors.
A medication mistake can occur due to a number of variables, such as inadequate order coordination between the doctor and pharmacist, improper storage practices in pharmacies, and misunderstandings arising from the use of identical labels.
Dispensing errors include any anomalies or deviations from the prescribing order, such as dispensing the wrong dose, drug, dosage type, incorrect amount, or insufficient, incorrect, or inadequate labeling. The misleading or insufficient instruction for use, improper planning, packaging, or storage of medication before dispensing is also considered a medication error.
In a pharmacy that fills 250 prescriptions per day, errors occur at a rate of 4 per day, amounting to an estimated 51.5 million errors out of 3 billion prescriptions filled annually across the nation.
- Rising Demand for Pharmaceuticals
The escalating demand for pharmaceuticals is observed across the globe due to the surging incidence of chronic diseases such as cancers, diabetes, obesity, and asthma among others. The people suffering from these diseases are dependent on one or the other medication prescribed to them by their physicians.
Also, the aging population is increasing Europe due to the availability of better healthcare facilities. Increased research and development leading to the launch of effective and novel medications oriented to specific diseases further aids in the surging demand for pharmaceuticals.
Moreover, the emergence of COVID-19 also has increased the demand for various medications worldwide which include vitamin-C tablets and hydroxychloroquine, among others leading to a significant rise in the demand for pharmaceuticals.
OPPORTUNITY
- Need for Increasing the Efficiency of Work within the Pharmacies
Every pharmacy is trying to do the same things which include correctly and efficiently filling prescriptions, providing high-quality patient care, and maintaining a sustainable business model in which workers have good job satisfaction and consumers are satisfied.
In order to improve the effectiveness of their pharmacy activities in support of overall hospital strategies and priorities to provide high-quality patient-centered care, many hospital and pharmacy leaders have started adopting pharmacy automation systems.
The adoption of enhanced workflow and pharmacy automation software and system has potentially increased the efficiency of the pharmacies. Thereby, the need for increasing the efficiency of work within the pharmacies acts as an opportunity for market growth.
RESTRAINT
- High Capital Investment
Pharmacy automation systems are more costly as compared to manual systems. The price of an average pharmacy automation system starts at USD 59,198.45 but for more exotic versions, it can be as high as USD 591,984.50.
Since the capital investment needed for the pharmacy automation system implementation is significantly high, it makes it difficult to adopt such systems in hospitals and pharmacies in developing nations along with small pharmacies across the globe. Thus, the high capital investment leads to the decreased adoption rate of pharmacy automation systems. Hence, it acts as a restraint for market growth.
CHALLENGE
- Stringent Regulatory Procedures
Hospitals and pharmacies are required to play a crucial role in the drug supply chain of the nation: the distribution of medicines to the public. Among the several regulations — state and federal — that regulate medicine dispensing practices, there are 3 important laws relating to the protection and security of both the general public and practitioners in the industry.
These laws apply to Drug supply chain protection, controlled substance regulation and safety, and pharmaceutical hazardous waste management — and are implemented by the FDA, DEA, and EPA.
Manufacturers of automated pharmaceutical systems, therefore, have to comply with various regulations; maintaining such compliance is a tedious job and can delay product launches. Thus, the stringency of regulatory procedures acts as a challenge to market growth.
Recent Developments
- In January 2023, AmerisourceBergen Corporation announced the completion of its acquisition of PharmaLex Holding GmbH. The acquisition of PharmaLex enhances AmerisourceBergen Corporation’s growth strategy by advancing its leadership in specialty services and Europe platform of pharma manufacturer services capabilities.
- In February 2022, Baxter announced that it has received authorization from the Common Vulnerability and Exposures (CVE) program to be a CVE Numbering Authority.
Europe Pharmacy Automation Market
The Europe pharmacy automation market is segmented into six notable segments based on product, pharmacy type, pharmacy size, application, end user, and distribution channel.
PRODUCT
- SYSTEMS
- SOFTWARE
- SERVICES
On the basis of product, the market is segmented into systems, software, and services.
PHARMACY TYPE
- INDEPENDENT
- CHAIN
- FEDERAL
On the basis of pharmacy type, the market is segmented into independent, chain, and federal.
PHARMACY SIZE
- LARGE SIZE PHARMACY
- MEDIUM SIZE PHARMACY
- SMALL SIZE PHARMACY
On the basis of pharmacy size, the market is segmented into large size pharmacy, medium size pharmacy, and small size pharmacy.
APPLICATION
- DRUG DISPENSING AND PACKAGING
- DRUG STORAGE
- INVENTORY MANAGEMENT
On the basis of application, the market is segmented into drug dispensing and packaging, drug storage, and inventory management.
END USER
- INPATIENT PHARMACIES
- OUTPATIENT PHARMACIES
- RETAIL PHARMACIES
- ONLINE PHARMACIES
- CENTRAL FILL/MAIL ORDER PHARMACIES
- PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS
- OTHERS
根据最终用户,市场细分为住院药房、门诊药房、零售药房、网上药房、中央配药/邮购药房、药房福利管理组织等。
分销渠道
- 直接招标
- 第三方分销商
根据分销渠道,市场分为直接招标和第三方分销商。
欧洲药房自动化市场区域分析/见解
欧洲药房自动化市场根据产品、药房类型、药房规模、应用、最终用户和分销渠道分为六个显著的部分。
本市场报告涵盖的国家包括德国、法国、意大利、英国、西班牙、荷兰、俄罗斯、瑞士、比利时、土耳其和欧洲其他国家。
2023 年,由于市场技术进步的提升,预计德国将主导欧洲地区。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战,以及销售渠道的影响。
竞争格局和欧洲药房自动化市场份额分析
欧洲药房自动化市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
欧洲药房自动化市场的一些主要市场参与者包括 Willach Group、McKesson Corporation、OMNICELL, INC.、Cerner Corporation、Capsa Healthcare、ScriptPro LLC、RxSafe, LLC.、MedAvail Technologies, Inc.、Asteres Inc.、InterLink AI, Inc.、BD、Baxter、Fullscript、Innovation Associates 和 AmerisourceBergen Corporation。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE PHARMACY AUTOMATION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 EUROPE PHARMACY AUTOMATION MARKET: REGULATIONS
4.1 EXISTING STATE LAWS AND REGULATIONS FOR THE USE OF AUTOMATED DISPENSING SYSTEMS (ADS) IN THE U.S.
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING NEED TO MINIMIZE MEDICATION ERRORS
5.1.2 RISING DEMAND FOR PHARMACEUTICALS
5.1.3 RISING LABOR COST
5.1.4 ADVANTAGES OF PHARMACY AUTOMATION SYSTEMS OVER MANUAL METHODS
5.1.5 TECHNOLOGICAL ADVANCEMENTS AND PRECISE ROBOTIC TOOLS
5.2 RESTRAINTS
5.2.1 RELUCTANCE AMONG THE HEALTHCARE ORGANIZATIONS TO ADOPT PHARMACY AUTOMATION SYSTEMS
5.2.2 HIGH CAPITAL INVESTMENT
5.2.3 INTEROPERABILITY PROBLEMS IN PHARMACY AUTOMATION
5.3 OPPORTUNITIES
5.3.1 NEED FOR INCREASING THE EFFICIENCY OF WORK WITHIN THE PHARMACIES
5.3.2 RISING HEALTHCARE EXPENDITURE IN EMERGING NATIONS
5.3.3 STRATEGIC INITIATIVES OF KEY MARKET PLAYERS
5.4 CHALLENGES
5.4.1 STRINGENCY OF REGULATORY PROCEDURES
5.4.2 SKILLED WORK-FORCE CHALLENGES
5.4.3 LIMITATIONS OF PHARMACY AUTOMATION SYSTEMS
6 EUROPE PHARMACY AUTOMATION MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 SYSTEMS
6.3 SOFTWARE
6.4 SERVICES
7 EUROPE PHARMACY AUTOMATION MARKET, BY PHARMACY TYPE
7.1 OVERVIEW
7.2 INDEPENDENT
7.3 CHAIN
7.4 FEDERAL
8 EUROPE PHARMACY AUTOMATION MARKET, BY PHARMACY SIZE
8.1 OVERVIEW
8.2 LARGE SIZE PHARMACY
8.3 MEDIUM SIZE PHARMACY
8.4 SMALL SIZE PHARMACY
9 EUROPE PHARMACY AUTOMATION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DISPENSING AND PACKAGING
9.3 DRUG STORAGE
9.4 INVENTORY MANAGEMENT
10 EUROPE PHARMACY AUTOMATION MARKET, BY END USER
10.1 OVERVIEW
10.2 INPATIENT PHARMACIES
10.3 OUTPATIENT PHARMACIES
10.4 RETAIL PHARMACIES
10.5 ONLINE PHARMACIES
10.6 CENTRAL FILL/MAIL ORDER PHARMACIES
10.7 PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS
10.8 OTHERS
11 EUROPE PHARMACY AUTOMATION MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTOR
12 EUROPE PHARMACY AUTOMATION MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 ITALY
12.1.4 U.K.
12.1.5 SPAIN
12.1.6 SWITZERLAND
12.1.7 RUSSIA
12.1.8 NETHERLANDS
12.1.9 BELGIUM
12.1.10 TURKEY
12.1.11 REST OF EUROPE
13 EUROPE PHARMACY AUTOMATION MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 OMNICELL, INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 MCKESSON CORPORATION
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 AMERISOURCEBERGEN CORPORATION
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 BAXTER
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 TOSHO CO., INC.
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 APD ALGORITMOS PROCESOS Y DISEÑOS S.A.
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 ASTERES INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 ARXIUM
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 BD
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 COMPANY SHARE ANALYSIS
15.9.4 PRODUCT PORTFOLIO
15.9.5 RECENT DEVELOPMENTS
15.1 BIQHS
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 CAPSA HEALTHCARE
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 CERNER CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 DEENOVA S.R.L.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 DEMODEKS PHARMACY SHELVING
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 FULLSCRIPT
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 GENESIS AUTOMATION LTD
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 IA
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 INTERLINK AI, INC
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 JVM EUROPE BV
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 KLS PHARMA ROBOTICS GMBH
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 KUKA AG
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 COMPANY SHARE ANALYSIS
15.21.4 PRODUCT PORTFOLIO
15.21.5 RECENT DEVELOPMENTS
15.22 MEDAVAIL TECHNOLOGIES, INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 MYPAK SOLUTIONS PTY LTD.
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 RXSAFE, LLC.
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 SCRIPTPRO LLC
15.25.1 COMPANY SNAPSHOT
15.25.2 COMPANY SHARE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENTS
15.26 SYNERGY MEDICAL
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENTS
15.27 TAKAZONO CORPORATION
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENTS
15.28 UNIVERSAL LOGISTICS HOLDINGS, INC.
15.28.1 COMPANY SNAPSHOT
15.28.2 REVENUE ANALYSIS
15.28.3 PRODUCT PORTFOLIO
15.28.4 RECENT DEVELOPMENTS
15.29 WILLACH GROUP
15.29.1 COMPANY SNAPSHOT
15.29.2 PRODUCT PORTFOLIO
15.29.3 RECENT DEVELOPMENTS
15.3 YUYAMA
15.30.1 COMPANY SNAPSHOT
15.30.2 PRODUCT PORTFOLIO
15.30.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
图片列表
FIGURE 1 EUROPE PHARMACY AUTOMATION MARKET: SEGMENTATION
FIGURE 2 EUROPE PHARMACY AUTOMATION MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE PHARMACY AUTOMATION MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PHARMACY AUTOMATION MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE PHARMACY AUTOMATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PHARMACY AUTOMATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE PHARMACY AUTOMATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE PHARMACY AUTOMATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE PHARMACY AUTOMATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE PHARMACY AUTOMATION MARKET: SEGMENTATION
FIGURE 11 GROWING NEED TO MINIMIZE MEDICATION ERRORS IS EXPECTED TO DRIVE THE EUROPE PHARMACY AUTOMATION MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PHARMACY AUTOMATION MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE PHARMACY AUTOMATION MARKET
FIGURE 14 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT, 2022
FIGURE 15 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT, 2023-2030 (USD
FIGURE 16 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, 2022
FIGURE 19 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, 2022
FIGURE 23 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, CAGR (2023-2030)
FIGURE 25 EUROPE PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, LIFELINE CURVE
FIGURE 26 EUROPE PHARMACY AUTOMATION MARKET: BY APPLICATION, 2022
FIGURE 27 EUROPE PHARMACY AUTOMATION MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE PHARMACY AUTOMATION MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 29 EUROPE PHARMACY AUTOMATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 EUROPE PHARMACY AUTOMATION MARKET: BY END USER, 2022
FIGURE 31 EUROPE PHARMACY AUTOMATION MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE PHARMACY AUTOMATION MARKET: BY END USER, CAGR (2023-2030)
FIGURE 33 EUROPE PHARMACY AUTOMATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 EUROPE PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 EUROPE PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 EUROPE PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 EUROPE PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 EUROPE PHARMACY AUTOMATION MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE PHARMACY AUTOMATION MARKET: BY COUNTRY (2022)
FIGURE 40 EUROPE PHARMACY AUTOMATION MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 EUROPE PHARMACY AUTOMATION MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 EUROPE PHARMACY AUTOMATION MARKET: BY PRODUCT (2023-2030)
FIGURE 43 EUROPE PHARMACY AUTOMATION MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.